Reversing obesity may also reduce a woman's chance of developing uterine cancer.
A phase 2 study finds that an inhibitor of CDK-4 and CDK-6 reduced the risk of disease progression by 51%.
Palonosetron and netupitant combo showed superior efficacy in controlling nausea and vomiting compared with palonosetron alone.
In a phase 1 study, the potent ALK inhibitor shows promise for treating NSCLC.
The need for additional treatment was reduced for younger patients who received radical prostatectomy.
New studies point to mortality benefits from PSA screening, but don't address the harms.
A new study supports the idea that the use of tanning beds is causing a sharp rise in melanoma incidence, particularly in middle-aged women.
Researchers are looking at new ways to determine pain levels in pediatric patients with cancer, and subsequently improving communication in all aspects of cancer care.
A study from the NIH/AARP show that mortality from colorectal cancers is affected by lifestyle factors such as smoking, alcohol consumption, and obesity.
For women with a BRCA mutation, delaying oophorectomy beyond age 35 sharply increases the risk of cancer and mortality.
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|